HU

Zoltan Varga

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zoltan Varga. Retrieved from https://idiyas.com/inventor/zoltan-varga-k5dxylkj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Zoltan Varga: Innovator in Antiviral Compounds

Introduction

Zoltan Varga is a notable inventor based in Hungary. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antiviral compounds. His work focuses on innovative chemical derivatives that have potential therapeutic applications.

Latest Patents

Zoltan Varga holds a patent for "Novel 4,6-Disubstituted Aminopyrimidine Derivatives Having Both Aromatic And Halogenic Substituents." This application relates to specific 4,6-disubstituted aminopyrimidine derivatives that possess both aromatic and halogenic substituents. These compounds are particularly valuable for their uses as antiviral and antiproliferative agents.

Career Highlights

Zoltan Varga is associated with Virostatics Srl, a company dedicated to the development of innovative antiviral therapies. His work at Virostatics Srl has positioned him as a key player in the fight against viral infections. Despite having no patents listed, his research contributions are noteworthy.

Collaborations

Zoltan has collaborated with esteemed colleagues such as Franco Lori and Gyorgy Keri. These partnerships have enhanced the scope and impact of his research in the field of antiviral compounds.

Conclusion

Zoltan Varga is an influential inventor whose work in antiviral compounds showcases his commitment to advancing medicinal chemistry. His innovative approach to developing new chemical derivatives holds promise for future therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…